JP5638008B2 - 皮膚治療方法 - Google Patents

皮膚治療方法 Download PDF

Info

Publication number
JP5638008B2
JP5638008B2 JP2011549394A JP2011549394A JP5638008B2 JP 5638008 B2 JP5638008 B2 JP 5638008B2 JP 2011549394 A JP2011549394 A JP 2011549394A JP 2011549394 A JP2011549394 A JP 2011549394A JP 5638008 B2 JP5638008 B2 JP 5638008B2
Authority
JP
Japan
Prior art keywords
euphorbia
skin
ingenol
pep005
hyaluronan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011549394A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012517450A (ja
JP2012517450A5 (https=
Inventor
スティーブン マーティン オグボーン
スティーブン マーティン オグボーン
デイビッド トーマス
デイビッド トーマス
ライアン モーズリー
ライアン モーズリー
ジェイムズ ハリソン エールワード
ジェイムズ ハリソン エールワード
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Laboratories Ltd
Original Assignee
Leo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Laboratories Ltd filed Critical Leo Laboratories Ltd
Publication of JP2012517450A publication Critical patent/JP2012517450A/ja
Publication of JP2012517450A5 publication Critical patent/JP2012517450A5/ja
Application granted granted Critical
Publication of JP5638008B2 publication Critical patent/JP5638008B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
JP2011549394A 2009-02-13 2010-02-12 皮膚治療方法 Expired - Fee Related JP5638008B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15259909P 2009-02-13 2009-02-13
US61/152,599 2009-02-13
PCT/AU2010/000152 WO2010091472A1 (en) 2009-02-13 2010-02-12 Skin treatment

Publications (3)

Publication Number Publication Date
JP2012517450A JP2012517450A (ja) 2012-08-02
JP2012517450A5 JP2012517450A5 (https=) 2013-04-04
JP5638008B2 true JP5638008B2 (ja) 2014-12-10

Family

ID=42561329

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011549394A Expired - Fee Related JP5638008B2 (ja) 2009-02-13 2010-02-12 皮膚治療方法

Country Status (14)

Country Link
US (1) US10143638B2 (https=)
EP (1) EP2395993B1 (https=)
JP (1) JP5638008B2 (https=)
CN (1) CN102316866A (https=)
AU (1) AU2010213362B2 (https=)
CA (1) CA2752389C (https=)
DK (1) DK2395993T3 (https=)
ES (1) ES2633755T3 (https=)
IL (1) IL214133A (https=)
NZ (1) NZ594184A (https=)
PL (1) PL2395993T3 (https=)
PT (1) PT2395993T (https=)
RU (1) RU2491050C2 (https=)
WO (1) WO2010091472A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9402823B2 (en) 2010-12-17 2016-08-02 Leo Laboratories Limited Ingenols for treating seborrheic keratosis
CN103402969A (zh) * 2010-12-22 2013-11-20 利奥实验室有限公司 3-酰基-巨大戟二萜醇ii
JP2014507396A (ja) * 2010-12-22 2014-03-27 レオ・ラボラトリーズ・リミテッド イノゲノール−３−アシラートｉ
WO2012176015A1 (en) 2011-06-24 2012-12-27 Leo Pharma A/S Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
US20140350101A1 (en) * 2011-12-12 2014-11-27 Leo Laboratories Limited Gel compositions
EP2790670A1 (en) * 2011-12-12 2014-10-22 Leo Laboratories Limited Gel compositions
US20150366789A1 (en) * 2013-03-13 2015-12-24 Avon Place, Inc. Glochidium wallichianum extracts and methods of use
US9526714B2 (en) 2014-03-24 2016-12-27 Leo Laboratories Limited Method for treating skin lesions with ingenol mebutate
AU2014100280B4 (en) * 2014-03-24 2015-01-15 Leo Pharma A/S A method of treating skin lesions
BR112018074202B1 (pt) * 2016-05-24 2022-08-02 Natura Cosméticos S.A Composição cosmética antissinais, kit de composições e método para tratamento cosmético da pele
JP7557192B2 (ja) 2020-08-19 2024-09-27 日本メナード化粧品株式会社 皮膚外用剤及び内用剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08176004A (ja) * 1994-12-21 1996-07-09 Lion Corp 生体老化防止剤及び皮膚用組成物
JPH0987136A (ja) * 1995-07-13 1997-03-31 Shiseido Co Ltd 皮膚外用剤
AUPO864097A0 (en) 1997-08-19 1997-09-11 Peplin Pty Ltd Anti-cancer compounds
AU750624B2 (en) * 1997-08-19 2002-07-25 Leo Laboratories Limited Anti-cancer compounds-I
KR20010057776A (ko) * 1999-12-23 2001-07-05 성재갑 피부미백제
JP4880816B2 (ja) 2000-12-15 2012-02-22 株式会社ヤクルト本社 皮膚老化防止剤
JP3935360B2 (ja) * 2002-01-22 2007-06-20 丸善製薬株式会社 ヒアルロン酸産生促進剤並びに皮膚化粧料及び美容用飲食品
RU2229293C1 (ru) * 2003-04-24 2004-05-27 Хазанов Вениамин Абрамович Лечебно-профилактическое средство для использования в геронтологической практике
US20070224150A1 (en) * 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
JP2007084448A (ja) * 2005-09-20 2007-04-05 Shiseido Co Ltd ヒアルロン酸産生促進剤および皮膚外用剤
BRPI0504797B1 (pt) 2005-10-27 2020-02-04 Pele Nova Biotecnologia S.A. formulação tópica, método de tratamento cosmético para rejuvenescimento da pele, método de tratamento cosmético e uso de uma formulação
KR20080077625A (ko) * 2005-11-25 2008-08-25 페플린 리서치 피티이 리미티드 상처 치유 방법
SI2152261T1 (sl) 2007-04-30 2016-05-31 Leo Laboratories Limited Zdravljenje viralno induciranih lezij
EP2558435B1 (en) * 2010-04-16 2017-06-07 Leo Pharma A/S Orthorhombic crystalline ingenol mebutate

Also Published As

Publication number Publication date
JP2012517450A (ja) 2012-08-02
RU2011137530A (ru) 2013-03-20
EP2395993B1 (en) 2017-06-21
AU2010213362A1 (en) 2011-08-04
PT2395993T (pt) 2017-07-18
NZ594184A (en) 2014-01-31
CN102316866A (zh) 2012-01-11
PL2395993T3 (pl) 2017-10-31
CA2752389C (en) 2017-01-03
US10143638B2 (en) 2018-12-04
CA2752389A1 (en) 2010-08-19
US20120041064A1 (en) 2012-02-16
WO2010091472A1 (en) 2010-08-19
EP2395993A4 (en) 2014-09-03
IL214133A0 (en) 2011-08-31
ES2633755T3 (es) 2017-09-25
DK2395993T3 (en) 2017-08-07
IL214133A (en) 2015-03-31
RU2491050C2 (ru) 2013-08-27
EP2395993A1 (en) 2011-12-21
AU2010213362B2 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
JP5638008B2 (ja) 皮膚治療方法
JP5497629B2 (ja) ウイルスにより誘発された病変の治療方法
CA2703532C (en) Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
CN101677925B (zh) 包含α-红没药醇作为活性成分的改善皮肤状况的组合物
EP3329913B1 (en) Composition for inhibiting formation of snare complex, containing myricetin derivatives
US8822477B2 (en) Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis
WO2017217695A1 (ko) 알파-망고스틴, 베타-망고스틴, 감마-망고스틴 또는 가르탄닌 화합물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 조성물
ES2606233T3 (es) Composiciones para el tratamiento de la rosácea que comprende quitosano y una amida de ácido dicarboxílico
WO2025223291A1 (zh) 神经酰胺ns及其合成方法和用途
US10238624B2 (en) Composition for activating longevity genes, containing kojic acid derivative as active ingredient
KR102152850B1 (ko) 글리세린 지방산 유도체의 용도
CN108174598A (zh) 抑制snare复合物形成的含有杨梅素衍生物的组合物
ES2958970T3 (es) Composiciones para uñas con propiedades antifúngicas
BR112021013365B1 (pt) Uso de uma combinação no preparo de uma composição tópica farmacêutica ou cosmética para unhas e tal composição
KR20190027415A (ko) 스워티아자포닌을 포함하는 피부 주름 개선용 조성물
JPWO2010073667A1 (ja) 紫外線防止剤

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20130109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140331

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140630

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140707

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140730

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140806

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140827

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141002

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141021

R150 Certificate of patent or registration of utility model

Ref document number: 5638008

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees